<?xml version="1.0"?>
<template xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="openEHR/v1/Template">
  <id>f8cb4b78-dfd3-4961-a7dc-ade677513121</id>
  <name>Endocarditis Prophylaxis, Adult Order Panel</name>
  <description>
    <lifecycle_state>Initial</lifecycle_state>
    <details>
      <purpose/>
      <use/>
      <misuse/>
    </details>
    <other_details>
      <item>
        <key>MetaDataSet:Sample Set </key>
        <value>Template metadata sample set </value>
      </item>
      <item>
        <key>Acknowledgements</key>
        <value/>
      </item>
      <item>
        <key>Business Process Level</key>
        <value/>
      </item>
      <item>
        <key>Care setting</key>
        <value/>
      </item>
      <item>
        <key>Client group</key>
        <value/>
      </item>
      <item>
        <key>Clinical Record Element</key>
        <value/>
      </item>
      <item>
        <key>Copyright</key>
        <value/>
      </item>
      <item>
        <key>Issues</key>
        <value/>
      </item>
      <item>
        <key>Owner</key>
        <value/>
      </item>
      <item>
        <key>Sign off</key>
        <value/>
      </item>
      <item>
        <key>Speciality</key>
        <value/>
      </item>
      <item>
        <key>User roles</key>
        <value/>
      </item>
    </other_details>
  </description>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]">
    <items>
      <item>
        <key>Technical.ﻩ Technical Traceability</key>
        <value>{~AHSID~f8cb4b78-dfd3-4961-a7dc-ade677513121~NAME~Endocarditis Prophylaxis, Adult Order Panel}</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Guidance Text - Conditions for Prophylaxis&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;&lt;strong&gt;Cardiac conditions associated with the highest risk of adverse outcome&lt;/strong&gt; from Endocarditis for which prophylaxis is reasonable:&lt;br&gt;&amp;nbsp; &amp;nbsp; &amp;nbsp;1.&amp;nbsp;&amp;nbsp; &amp;nbsp;Prosthetic cardiac valve or prosthetic material used for cardiac valve repair&lt;br&gt;&amp;nbsp; &amp;nbsp; &amp;nbsp;2.&amp;nbsp;&amp;nbsp; &amp;nbsp;Previous infective endocarditis&lt;br&gt;&amp;nbsp; &amp;nbsp; &amp;nbsp;3.&amp;nbsp;&amp;nbsp; &amp;nbsp;Congenital heart disease (CHD):&lt;br&gt;&amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; a.&amp;nbsp;&amp;nbsp; &amp;nbsp;Unrepaired cyanotic CHD, including palliative shunts and conduits&lt;br&gt;&amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; b.&amp;nbsp;&amp;nbsp; &amp;nbsp;Completely repaired congenital heart defect with prosthetic material or device, whether placed by surgery or by catheter intervention, during the first six (6) months after the procedure&lt;br&gt;&amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; c.&amp;nbsp;&amp;nbsp; &amp;nbsp;Repaired CHD with residual defects at the site or adjacent to the site of a prosthetic patch or prosthetic device (which inhibit endothelialization)&lt;br&gt;&amp;nbsp; &amp;nbsp; &amp;nbsp;4.&amp;nbsp;&amp;nbsp; &amp;nbsp;Cardiac transplantation recipients who develop cardiac valvulopathy&lt;br&gt;&amp;nbsp;&lt;br&gt;&lt;strong&gt;Dental Procedures&lt;/strong&gt; for which prophylaxis is reasonable for patients at high risk as listed above:&lt;br&gt;&amp;nbsp; &amp;nbsp; &amp;nbsp;1.&amp;nbsp;&amp;nbsp; &amp;nbsp;Procedures that involve manipulation of gingival tissue or the periapical region of teeth or perforation of the oral mucosa&amp;nbsp;&lt;br&gt;&amp;nbsp;&lt;br&gt;The following Dental Procedures and events &lt;u&gt;DO NOT&lt;/u&gt; need prophylaxis:&amp;nbsp;&lt;br&gt;&amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp;&amp;nbsp; &amp;nbsp;Routine anesthetic injections through non-infected tissue&amp;nbsp;&lt;br&gt;&amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp;&amp;nbsp; &amp;nbsp;Taking dental radiographs&amp;nbsp;&lt;br&gt;&amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp;&amp;nbsp; &amp;nbsp;Placement of removable prosthodontic or orthodontic appliances&lt;br&gt;&amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp;&amp;nbsp; &amp;nbsp;Adjustment of orthodontic appliances&amp;nbsp;&lt;br&gt;&amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp;&amp;nbsp; &amp;nbsp;Placement of orthodontic brackets&lt;br&gt;&amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp;&amp;nbsp; &amp;nbsp;Shedding of deciduous teeth&lt;br&gt;&amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp;&amp;nbsp; &amp;nbsp;Bleeding from trauma to the lips or oral mucosa&amp;nbsp;&lt;br&gt;&amp;nbsp;&lt;br&gt;&lt;strong&gt;Respiratory Tract Procedures:&lt;/strong&gt;&lt;br&gt;&amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp;&amp;nbsp; &amp;nbsp;Antibiotic prophylaxis with regimen below is reasonable (Class IIa, LOE C) for patients with the conditions listed above who undergo an invasive procedure of the respiratory tract that involves incision or biopsy of the respiratory mucosa, such as tonsillectomy and adenoidectomy&lt;br&gt;&amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp;&amp;nbsp; &amp;nbsp;Consider prophylaxis for patients having&amp;nbsp;respiratory tract procedures&amp;nbsp;to treat an established infection, such as abscess drainage, with an antibiotic regimen containing an agent active against viridans group streptococci (for example, amoxicillin or cefazolin), and if&amp;nbsp;Staphylococcus aureus&amp;nbsp;is known or suspected, an antistaphylococcal penicillin or cephalosporin (or vancomycin if the patient is unable to tolerate a beta-lactam or if suspected or known methicillin-resistant&amp;nbsp;S. Aureus).&lt;br&gt;&amp;nbsp;&lt;br&gt;&lt;strong&gt;Gastrointestinal/Genitourinary Procedures:&lt;/strong&gt;&amp;nbsp;&lt;br&gt;&amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp;&amp;nbsp; &amp;nbsp;Antibiotic prophylaxis solely to prevent infective endocarditis (IE) is no longer recommended for patients who undergo a GI or GU tract procedures including esophagogastroduodenoscopy or colonoscopy&lt;br&gt;&amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp;&amp;nbsp; &amp;nbsp;However, consider (Class IIb, LOE B) endocarditis prophylaxis for patients having gastrointestinal or genitourinary procedures&amp;nbsp;if there is either an existing infection or if antibiotic therapy is indicated for such procedures &amp;nbsp;&lt;br&gt;&amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp;&amp;nbsp; &amp;nbsp;Consider using an antibiotic regimen which includes an agent that has activity against enterococci such as ampicillin or amoxicillin (or vancomycin if the patient is unable to tolerate a beta-lactam)&lt;br&gt;&amp;nbsp;&lt;br&gt;&lt;strong&gt;If patient is already receiving an antibiotic which is recommended for endocarditis prophylaxis:&lt;/strong&gt;&lt;br&gt;&amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp;&amp;nbsp; &amp;nbsp;Select an antibiotic for prophylaxis from a different class than the one the patient is already receiving for treatment (e.g. use clindamycin or a macrolide if patient receiving a beta-lactam)&lt;br&gt;&amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp;&amp;nbsp; &amp;nbsp;If possible, delay procedure until at least 10 days after completion of antibiotic treatment course&lt;br&gt;- &lt;u&gt;&lt;strong&gt;Link to AHA Guideline: Prevention of Infective Endocarditis&lt;/strong&gt;&lt;/u&gt;&lt;br&gt;-&amp;nbsp;&lt;u&gt;&lt;strong&gt;Link to Bugs &amp;amp; Drugs: Prophylaxis for Infective Endocarditis&lt;/strong&gt;&lt;/u&gt;&amp;nbsp;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Guidance Text - Conditions for Prophylaxis&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;N&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Prophylaxis for Dental, Oral, Respiratory Tract Procedures&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1 and name/value=&apos;Clinical Guidance&apos;]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;If antibiotic prophylaxis is inadvertently not taken before the dental procedure, it can be taken up to 2 hours after the procedure.&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Prophylaxis for Dental, Oral, Respiratory Tract Procedures&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Oral medication&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;N&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Prophylaxis for Dental, Oral, Respiratory Tract Procedures&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Unable to take oral medication&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;N&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Prophylaxis for Dental, Oral, Respiratory Tract Procedures&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Unable to take oral medication&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;ceFAZolin injection; 1 g, intravenous, once, 30-60 minutes prior to procedure for endocarditis prophylaxis #1&apos;]/activities[at0001]">
    <items>
      <item>
        <key>Transform.Technical Notes</key>
        <value>&lt;p&gt;This should be intramuscular&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Prophylaxis for Dental, Oral, Respiratory Tract Procedures&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Allergic to penicillins or ampicillin - oral medication&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;N&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Prophylaxis for Dental, Oral, Respiratory Tract Procedures&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Allergic to penicillins or ampicillin - oral medication&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1 and name/value=&apos;Clinical Guidance&apos;]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;Although cephalexin is still recommended in the 2021 AHA guidelines, it is not a good option as the majority of Viridans Group Streptococci are resistant to cephalexin.&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Prophylaxis for Dental, Oral, Respiratory Tract Procedures&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Allergic to penicillins, ampicillin or amoxicillin, and unable to take oral medication&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1 and name/value=&apos;Clinical Guidance&apos;]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;** Cephalosporins should not be used in an individual with a history of anaphylaxis, angioedema, or urticaria with penicillin or ampicillin.&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Prophylaxis for Dental, Oral, Respiratory Tract Procedures&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Allergic to penicillins, ampicillin or amoxicillin, and unable to take oral medication&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;N&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Prophylaxis for Dental, Oral, Respiratory Tract Procedures&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;Y&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <definition xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" name="Endocarditis Prophylaxis, Adult">
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Guidance Text - Conditions for Prophylaxis">
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
    </Item>
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Prophylaxis for Dental, Oral, Respiratory Tract Procedures">
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Oral medication">
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="3c558a0f-62d3-43d6-80b8-b5b51bd3b740" concept_name="PHARM amoxicillin Capsule Order" max="1" path="/items" name="amoxicillin Capsule; 2,000 mg, oral, once, 30-60 minutes prior to procedure for endocarditis prophylaxis"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
      </Item>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR"/>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Unable to take oral medication">
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="efb7f546-10b0-4aad-a930-97faaf58e5e2" concept_name="PHARM ampicillin injection Order" max="1" path="/items" name="ampicillin Injection; 2 g, intravenous, once, 30-60 minutes prior to procedure for endocarditis prophylaxis"/>
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="efb7f546-10b0-4aad-a930-97faaf58e5e2" concept_name="PHARM ampicillin injection Order" max="1" path="/items" name="ampicillin injection; 2 g, intramuscular, once, 30-60 minutes prior to procedure for endocarditis prophylaxis"/>
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR #1"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="d8ff3407-9c0a-4e65-9cc2-b91041b4451a" concept_name="PHARM ceFAZolin injection Order" max="1" path="/items" name="ceFAZolin injection; 1 g, intravenous, once, 30-60 minutes prior to procedure for endocarditis prophylaxis"/>
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR #2"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="d8ff3407-9c0a-4e65-9cc2-b91041b4451a" concept_name="PHARM ceFAZolin injection Order" max="1" path="/items" name="ceFAZolin injection; 1 g, intravenous, once, 30-60 minutes prior to procedure for endocarditis prophylaxis #1"/>
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR #3"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="46facdb5-2f39-40f1-9c04-7f66e4c25df5" concept_name="PHARM cefTRIAXone injection Order" max="1" path="/items" name="cefTRIAXone injection; 1 g, intravenous, once, 30-60 minutes prior to procedure for endocarditis prophylaxis"/>
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR #4"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="46facdb5-2f39-40f1-9c04-7f66e4c25df5" concept_name="PHARM cefTRIAXone injection Order" max="1" path="/items" name="cefTRIAXone injection; 1 g, intramuscular, once, 30-60 minutes prior to procedure for endocarditis prophylaxis"/>
      </Item>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR #1"/>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Allergic to penicillins or ampicillin - oral medication">
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="12aa6a8f-63ce-464c-a35b-b1462cc041a2" concept_name="PHARM cephaLEXIN Tablet Order" max="1" path="/items" name="cephaLEXIN Tablet; 2,000 mg, oral, once, 30-60 minutes prior to procedure for endocarditis prophylaxis"/>
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="372c5d60-a44e-4a28-9d6e-8b5a5a41eae4" concept_name="PHARM AZIthromycin Tablet Order" max="1" path="/items" name="AZIthromycin Tablet; 500 mg, oral, once, 30-60 minutes prior to procedure for endocarditis prophylaxis"/>
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR #1"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="b599544a-158f-4856-97d8-6284930c5b5d" concept_name="PHARM clarithromycin Tablet Order" max="1" path="/items" name="clarithromycin Tablet; 500 mg, oral, once, 30-60 minutes prior to procedure for endocarditis prophylaxis"/>
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR #2"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="6c343f9d-ab54-4fd7-8b40-6c42c6356b51" concept_name="PHARM doxycycline Capsule Order" max="1" path="/items" name="doxycycline Capsule; 100 mg, oral, once, 30-60 minutes prior to procedure for endocarditis prophylaxis"/>
      </Item>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR #2"/>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Allergic to penicillins, ampicillin or amoxicillin, and unable to take oral medication">
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="d8ff3407-9c0a-4e65-9cc2-b91041b4451a" concept_name="PHARM ceFAZolin injection Order" max="1" path="/items" name="ceFAZolin Injection; 1 g, intravenous, once, 30-60 minutes prior to procedure for endocarditis prophylaxis"/>
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="d8ff3407-9c0a-4e65-9cc2-b91041b4451a" concept_name="PHARM ceFAZolin injection Order" max="1" path="/items" name="ceFAZolin injection; 1 g, intramuscular, once, 30-60 minutes prior to procedure for endocarditis prophylaxis"/>
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR #1"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="46facdb5-2f39-40f1-9c04-7f66e4c25df5" concept_name="PHARM cefTRIAXone injection Order" max="1" path="/items" name="cefTRIAXone Injection; 1 g, intravenous, once, 30-60 minutes prior to procedure for endocarditis prophylaxis"/>
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR #2"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="46facdb5-2f39-40f1-9c04-7f66e4c25df5" concept_name="PHARM cefTRIAXone injection Order" max="1" path="/items" name="cefTRIAXone injection; 1 g, intramuscular, once, 30-60 minutes prior to procedure for endocarditis prophylaxis"/>
      </Item>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
    </Item>
  </definition>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.adhoc.v1">
    <digest id="MD5-CAM-1.0.1">8AE70853975A75254E6D39A8DE3652AF</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1">
    <digest id="MD5-CAM-1.0.1">4B2F0F6CD593E442DA9C30277A3EA9CF</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1">
    <digest id="MD5-CAM-1.0.1">A7EC4E4C870D8C3431B29F6514353416</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1">
    <digest id="MD5-CAM-1.0.1">AD8DFB192E67715F0D9E11E95E674AD0</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-CLUSTER.service_request_information.v1">
    <digest id="MD5-CAM-1.0.1">230A8D964017E1FD7AC82EBDEE0202A6</digest>
  </integrity_checks>
</template>